Keikkala E, Forst xe9 n J, Ritvos O, Stenman U, Kajantie E, H xe4 m xe4 l xe4 inen E, et al. Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women. Pregnancy Hypertens. 2021;25:116-122 pubmed publisher

Wang J, Hu H, Liu X, Zhao S, Zheng Y, Jia Z, et al. Predictive values of various serum biomarkers in women with suspected preeclampsia: A prospective study. J Clin Lab Anal. 2021;35:e23740 pubmed publisher

Neuman R, Alblas van der Meer M, Nieboer D, Saleh L, Verdonk K, Kalra B, et al. PAPP-A2 and Inhibin A as Novel Predictors for Pregnancy Complications in Women With Suspected or Confirmed Preeclampsia. J Am Heart Assoc. 2020;9:e018219 pubmed publisher

Hjortebjerg R, Espelund U, Rasmussen T, Folkersen B, Steiniche T, Georgsen J, et al. Pregnancy-Associated Plasma Protein-A2 Is Associated With Mortality in Patients With Lung Cancer. Front Endocrinol (Lausanne). 2020;11:614 pubmed publisher

Frystyk J, Teran E, Gude M, Bjerre M, Hjortebjerg R. Pregnancy-associated plasma proteins and Stanniocalcin-2 - Novel players controlling IGF-I physiology. Growth Horm IGF Res. 2020;53-54:101330 pubmed publisher

Fujimoto M, Khoury J, Khoury P, Kalra B, Kumar A, Sluss P, et al. Anthropometric and biochemical correlates of PAPP-A2, free IGF-I, and IGFBP-3 in childhood. Eur J Endocrinol. 2020;182:363-374 pubmed publisher

Dereke J, Nilsson C, Strevens H, Landin Olsson M, Hillman M. Pregnancy-associated plasma protein-A2 levels are increased in early-pregnancy gestational diabetes: a novel biomarker for early risk estimation. Diabet Med. 2020;37:131-137 pubmed publisher

DiPrisco B, Kumar A, Kalra B, Savjani G, Michael Z, Farr O, et al. Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length. Metabolism. 2019;100:153959 pubmed publisher

Cabrera Salcedo C, Mizuno T, Tyzinski L, Andrew M, Vinks A, Frystyk J, et al. Pharmacokinetics of IGF-I in PAPP-A2 Deficient Patients, Growth Response, and Effects on Glucose and Bone Density. J Clin Endocrinol Metab. 2017;: pubmed publisher

Espelund U, Bjerre M, Hjortebjerg R, Rasmussen T, Lundby A, Hoeflich A, et al. Insulin-Like Growth Factor Bioactivity, Stanniocalcin-2, Pregnancy-Associated Plasma Protein-A, and IGF-Binding Protein-4 in Pleural Fluid and Serum From Patients With Pulmonary Disease. J Clin Endocrinol Metab. 2017;102:3526-3534 pubmed publisher

Steinbrecher A, Janke J, Poy M, Oxvig C, Pischon T. Pregnancy-Associated Plasma Protein-A2 and Anthropometry, Lifestyle, and Biochemical Factors in a Human Adult Population. Sci Rep. 2017;7:10455 pubmed publisher

Dauber A, Muñoz Calvo M, Barrios V, Domene H, Kloverpris S, Serra Juhé C, et al. Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability. EMBO Mol Med. 2016;8:363-74 pubmed publisher

Hansen Y, Myrh xf8 j V, J xf8 rgensen F, Oxvig C, S xf8 rensen S. First trimester PAPP-A2, PAPP-A and hCGβ in small-for-gestational-age pregnancies. Clin Chem Lab Med. 2016;54:117-23 pubmed publisher

Munnangi S, Gross S, Madankumar R, Salcedo G, Reznik S. Pregnancy associated plasma protein-A2: a novel biomarker for Down syndrome. Placenta. 2014;35:900-6 pubmed publisher

Kløverpris S, Gaidamauskas E, Rasmussen L, Overgaard M, Kronborg C, Knudsen U, et al. A robust immunoassay for pregnancy-associated plasma protein-A2 based on analysis of circulating antigen: establishment of normal ranges in pregnancy. Mol Hum Reprod. 2013;19:756-63 pubmed publisher